Submission for OMB Review; National Medical Support Notice-Part A, 33266-33267 [2019-14834]
Download as PDF
<![CDATA[
33266
Federal Register / Vol. 84, No. 134 / Friday, July 12, 2019 / Notices
which is generally viewed as a faster
payment alternative offered by those
depository institutions. In addition, the
FR 3066b attempts to collect
comprehensive fraud data from P2P and
money transfer processors, including
those processors offering faster payment
methods. The Board will retain the
questions as written.
Board of Governors of the Federal Reserve
System, July 9, 2019.
Michele Taylor Fennell,
Assistant Secretary of the Board.
[FR Doc. 2019–14874 Filed 7–11–19; 8:45 am]
All employees of the Department of
Energy, its predecessor agencies, and their
contractors and subcontractors who worked
at the Idaho National Laboratory (INL) in
Scoville, Idaho, and who were monitored for
external radiation at the Idaho Chemical
Processing Plant (CPP) (e.g., at least one film
badge or TLD dosimeter from CPP) between
January 1, 1963, and February 28, 1970, for
a number of work days aggregating at least
250 work days, occurring either solely under
this employment, or in combination with
work days within the parameters established
for one or more other classes of employees
in the Special Exposure Cohort.
This designation will become effective
on July 21, 2019, unless Congress
provides otherwise prior to the effective
date. After this effective date, HHS will
publish a notice in the Federal Register
reporting the addition of this class to the
SEC or the result of any provision by
Congress regarding the decision by HHS
to add the class to the SEC.
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Designation of a Class of Employees
for Addition to the Special Exposure
Cohort
Authority: 42 U.S.C. 7384q(b). 42 U.S.C.
7384l(14)(C).
National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention, Department of Health
and Human Services (HHS).
ACTION: Notice.
[FR Doc. 2019–14816 Filed 7–11–19; 8:45 am]
AGENCY:
HHS gives notice of a
decision to designate a class of
employees from the Idaho National
Laboratory in Scoville, Idaho, as an
addition to the Special Exposure Cohort
(SEC) under the Energy Employees
Occupational Illness Compensation
Program Act of 2000.
FOR FURTHER INFORMATION CONTACT:
Grady Calhoun, Director, Division of
Compensation Analysis and Support,
NIOSH, 1090 Tusculum Avenue, MS C–
46, Cincinnati, OH 45226–1938,
Telephone 1–877–222–7570.
Information requests can also be
submitted by email to DCAS@CDC.GOV.
SUPPLEMENTARY INFORMATION: On June
21, 2019, as provided for under 42
U.S.C. 7384l(14)(C), the Secretary of
HHS designated the following class of
employees as an addition to the SEC:
SUMMARY:
John J. Howard,
Director, National Institute for Occupational
Safety and Health.
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review; National
Medical Support Notice—Part A
Office of Child Support
Enforcement; Administration for
Children and Families; HHS.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families (ACF) is
requesting a three year extension of the
form National Medical Support Notice
(NMSN) Part A (OMB #0970–0222
expiration 8/31/2019). Changes were
made to the form based on comments
received during the 60 day Notice.
SUMMARY:
Comments due within 30 days of
publication. OMB is required to make a
decision concerning the collection of
information between 30 and 60 days
after publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
DATES:
Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV. Attn:
Desk Officer for the Administration for
Children and Families.
Copies of the proposed collection may
be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research
and Evaluation, 330 C Street SW,
Washington, DC 20201, Attn: OPRE
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. Email address:
OPREinfocollection@acf.hhs.gov.
SUPPLEMENTARY INFORMATION:
Description: The National Medical
Support Notice (NMSN) is a two-part
document completed by state child
support enforcement agencies,
employers, and health plan
administrators to enforce health care
coverage provisions in a child support
order. The Department of Health and
Human Services (DHHS) developed and
maintains Part A of the NMSN, which
is sent to an obligor’s employer for
completion; the Department of Labor
(DOL) developed and maintains Part B
of the NMSN, which is provided to
health care administrators following
completion of Part A.
The Administration for Children and
Families is requesting that the NMSN
Part A expiration dates continue to be
synchronize with the expiration date of
NMSN Part B submitted by DOL.
Respondents: State child support
enforcement agencies, employers, and
health plan administrators.
ADDRESSES:
jbell on DSK3GLQ082PROD with NOTICES
ANNUAL BURDEN ESTIMATES
Instrument
Respondents
National Medical Support Notice—Part A—Notice to Withhold for Health Care Coverage.
State ..............
Employers ......
Estimated Total Annual Burden
Hours: 1,644,725.
VerDate Sep<11>2014
16:55 Jul 11, 2019
Jkt 247001
Annual
number of
respondents
54
1,275,624
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
89,634
3.79
Average
burden hours
per response
.17
.17
Annual
burden hours
822,840
821,885
information is necessary for the proper
performance of the functions of the
agency, including whether the
E:\FR\FM\12JYN1.SGM
12JYN1
Federal Register / Vol. 84, No. 134 / Friday, July 12, 2019 / Notices
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authorities: Section 466(a)(19) of the
Social Security Act (42 U.S.C.
666(a)(19)), section 609(a)(5)(C) of the
Employee Retirement Income Security
Act of 1974 (ERISA) (29 U.S.C.
1169(a)(5)(C)), and for State and local
government and church plans sections
401(e) and (f) of the Child Support
Performance and Incentive Act of 1998
(29 CFR 2590.609–2).
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2019–14834 Filed 7–11–19; 8:45 am]
BILLING CODE 4184–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–N–1346]
Development of Antiviral Drugs for the
Treatment of Adenoviral Infection in
Immunocompromised Patients; Public
Workshop; Cancellation
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration is announcing the
cancellation of a public workshop
entitled ‘‘Development of Antiviral
Drugs for the Treatment of Adenoviral
Infection in Immunocompromised
Patients’’ that was previously scheduled
for August 8, 2019, from 8:30 a.m. to
4:30 p.m. This public workshop was
announced in the Federal Register of
May 2, 2019. The meeting has been
cancelled due to unforeseen changes in
the adenovirus drug development
landscape.
SUMMARY:
Lori
Benner and/or Jessica Barnes, Center for
Drug Evaluation and Research, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, Rm. 6221,
Silver Spring, MD 20993–0002, 301–
796–1300, about this public workshop,
which was announced in the Federal
Register of May 2, 2019 (84 FR 18848).
jbell on DSK3GLQ082PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
VerDate Sep<11>2014
16:55 Jul 11, 2019
Jkt 247001
Dated: July 8, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–14887 Filed 7–11–19; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–D–2398]
Population Pharmacokinetics; Revised
Draft Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a revised
draft guidance for industry entitled
‘‘Population Pharmacokinetics.’’ This
revised draft guidance assists sponsors
in the application of population
pharmacokinetics (population PK)
during the drug development process to
inform drug use and includes FDA’s
current thinking on the data and model
requirements for population PK
analyses submitted as part of new drug
applications (NDAs) and biologic
license applications (BLAs). The revised
draft guidance also provides
expectations regarding the format and
content of the population PK report as
well as any labeling recommendations
resulting from such analyses.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
either electronic or written comments
on the draft guidance by September 10,
2019.
ADDRESSES: You may submit comments
as follows:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
33267
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA 2019–
D–2398 for ‘‘Population
Pharmacokinetics.’’ Received comments
will be placed in the docket and, except
for those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
E:\FR\FM\12JYN1.SGM
12JYN1
]]>Agencies
[Federal Register Volume 84, Number 134 (Friday, July 12, 2019)]
[Notices]
[Pages 33266-33267]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-14834]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; National Medical Support Notice--Part
A
AGENCY: Office of Child Support Enforcement; Administration for
Children and Families; HHS.
ACTION: Request for public comment.
-----------------------------------------------------------------------
SUMMARY: The Administration for Children and Families (ACF) is
requesting a three year extension of the form National Medical Support
Notice (NMSN) Part A (OMB #0970-0222 expiration 8/31/2019). Changes
were made to the form based on comments received during the 60 day
Notice.
DATES: Comments due within 30 days of publication. OMB is required to
make a decision concerning the collection of information between 30 and
60 days after publication of this document in the Federal Register.
Therefore, a comment is best assured of having its full effect if OMB
receives it within 30 days of publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent directly to the following: Office
of Management and Budget, Paperwork Reduction Project, Email:
[email protected]. Attn: Desk Officer for the Administration
for Children and Families.
Copies of the proposed collection may be obtained by writing to the
Administration for Children and Families, Office of Planning, Research
and Evaluation, 330 C Street SW, Washington, DC 20201, Attn: OPRE
Reports Clearance Officer. All requests should be identified by the
title of the information collection. Email address:
[email protected].
SUPPLEMENTARY INFORMATION:
Description: The National Medical Support Notice (NMSN) is a two-
part document completed by state child support enforcement agencies,
employers, and health plan administrators to enforce health care
coverage provisions in a child support order. The Department of Health
and Human Services (DHHS) developed and maintains Part A of the NMSN,
which is sent to an obligor's employer for completion; the Department
of Labor (DOL) developed and maintains Part B of the NMSN, which is
provided to health care administrators following completion of Part A.
The Administration for Children and Families is requesting that the
NMSN Part A expiration dates continue to be synchronize with the
expiration date of NMSN Part B submitted by DOL.
Respondents: State child support enforcement agencies, employers,
and health plan administrators.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Annual number Number of Average
Instrument Respondents of responses per burden hours Annual burden
respondents respondent per response hours
----------------------------------------------------------------------------------------------------------------
National Medical Support State............. 54 89,634 .17 822,840
Notice--Part A--Notice to
Withhold for Health Care
Coverage.
Employers......... 1,275,624 3.79 .17 821,885
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 1,644,725.
Comments: The Department specifically requests comments on (a)
whether the proposed collection of information is necessary for the
proper performance of the functions of the agency, including whether
the
[[Page 33267]]
information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Authorities: Section 466(a)(19) of the Social Security Act (42
U.S.C. 666(a)(19)), section 609(a)(5)(C) of the Employee Retirement
Income Security Act of 1974 (ERISA) (29 U.S.C. 1169(a)(5)(C)), and for
State and local government and church plans sections 401(e) and (f) of
the Child Support Performance and Incentive Act of 1998 (29 CFR
2590.609-2).
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2019-14834 Filed 7-11-19; 8:45 am]
BILLING CODE 4184-14-P
